Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 2
2016 1
2017 2
2018 2
2019 3
2020 5
2021 5
2022 5
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Cadherin-17 as a target for the immunoPET of adenocarcinoma.
Delaney S, Keinänen O, Lam D, Wolfe AL, Hamakubo T, Zeglis BM. Delaney S, et al. Among authors: keinanen o. Eur J Nucl Med Mol Imaging. 2024 Apr 16. doi: 10.1007/s00259-024-06709-7. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38625402
Evaluating CD133 as a Radiotheranostic Target in Small-Cell Lung Cancer.
Sarrett SM, Rodriguez C, Delaney S, Hosny MM, Sebastiano J, Santos-Coquillat A, Keinänen OM, Carter LM, Lastwika KJ, Lampe PD, Zeglis BM. Sarrett SM, et al. Among authors: keinanen om. Mol Pharm. 2024 Mar 4;21(3):1402-1413. doi: 10.1021/acs.molpharmaceut.3c01063. Epub 2024 Feb 8. Mol Pharm. 2024. PMID: 38331430 Free PMC article.
Molecular Imaging, Radiochemistry, and Environmental Pollutants.
Delaney S, Sebastiano J, Zeglis BM, Keinänen OM. Delaney S, et al. Among authors: keinanen om. J Nucl Med. 2023 Aug;64(8):1179-1184. doi: 10.2967/jnumed.122.265209. Epub 2023 Jul 13. J Nucl Med. 2023. PMID: 37442598 Free PMC article. Review.
Visualizing Galectin-3 Binding Protein Expression with ImmunoPET.
Keinänen O, Sarrett SM, Delaney S, Rodriguez C, Dayts EJ, Capone E, Sauniere F, Ippoliti R, Sala G, Iacobelli S, Zeglis BM. Keinänen O, et al. Mol Pharm. 2023 Jun 5;20(6):3241-3248. doi: 10.1021/acs.molpharmaceut.3c00241. Epub 2023 May 16. Mol Pharm. 2023. PMID: 37191353 Free PMC article.
Antibody Engineering for Nuclear Imaging and Radioimmunotherapy.
Rodriguez C, Delaney S, Sarrett SM, Keinänen OM, Zeglis BM. Rodriguez C, et al. Among authors: keinanen om. J Nucl Med. 2022 Sep;63(9):1316-1322. doi: 10.2967/jnumed.122.263861. Epub 2022 Jul 21. J Nucl Med. 2022. PMID: 35863894 Free PMC article.
ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic Antibody.
Sharma SK, Mack KN, Piersigilli A, Pourat J, Edwards KJ, Keinänen O, Jiao MS, Zhao H, White B, Brooks CL, de Stanchina E, Madiyalakan MR, Hollingsworth MA, Radhakrishnan P, Lewis JS, Zeglis BM. Sharma SK, et al. Among authors: keinanen o. Clin Cancer Res. 2022 Mar 1;28(5):948-959. doi: 10.1158/1078-0432.CCR-21-1798. Clin Cancer Res. 2022. PMID: 34907079 Free PMC article.
27 results